Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...

However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a ...

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period.

Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...

Millions of NHS patients could wait 12 years for weight-loss drug Mounjaro, which rivals Ozempic and Wegovy. Although the injections will be given out from March, the health service is too ...

The Mounjaro jab has been branded the “King Kong of weight-loss drugs” and could offer life-changing support for people in the UK struggling with obesity. It’s been advised that people with ...

The Mounjaro jab has been branded the “King Kong of weight-loss drugs” and could offer life-changing support for people in the UK struggling with obesity. It’s been advised that people with a body ...

The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body mass index (BMI) of more than 35 and at least one weight-related illness.